Dr. Petros E. Tsambiras, MD

Dr. Tsambiras practices at AdventHealth Zephyrhills in Zephyrhills, Florida, part of AdventHealth.

Dr. Tsambiras' NPI, 1760593263, was assigned on August 31, 2006. Dr. Tsambiras graduated from USF Health Morsani College of Medicine in 1996. Dr. Tsambiras holds Florida license ME74672.

Dr. Tsambiras' primary practice is AdventHealth Zephyrhills, at 7050 Gall Blvd, Zephyrhills, FL 33541 in Pasco County. The practice phone is (813) 615-7219.

Dr. Tsambiras' primary practice is AdventHealth Zephyrhills in Zephyrhills, Florida, part of AdventHealth. Dr. Tsambiras is also affiliated with AdventHealth Tampa. The medical group on file is Florida Medical Clinic Orlando Health. Dmand AI also links Dr. Tsambiras to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tsambiras practices, 5 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Tsambiras' primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Tsambiras is board certified in infectious disease by the American Board of Internal Medicine. Dr. Tsambiras is licensed in Florida.

Dmand AI lists acute sinusitis, acute skin infection, hiv/aids, joint or bone infection, pneumonia and UTI among the conditions Dr. Tsambiras treats.

CMS data shows 1,410 Medicare services from Dr. Tsambiras across 8 procedure codes in 2024, for 359 Medicare patients. Medicare paid $109,681 for them.

CMS counts 359 Medicare patients who saw Dr. Tsambiras in 2024. The largest group is 75 to 84, with 147 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 35% are also on Medicaid. Their average risk score is 3.39, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tsambiras' median patient age at 75, with 45% women.

In 2024, Dr. Tsambiras wrote 898 Medicare Part D claims for 163 patients. 66% of them were for generic drugs. CMS names the drug for 780 of them, across 26 drugs with 11 or more claims each, at $990,235 in total drug cost. In 2023, CMS named 916 claims across 28 drugs.

Dr. Tsambiras accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 38 procedures of removal of tissue by Dr. Tsambiras, more than 76% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Tsambiras. Dr. Tsambiras' most frequent co-authors are Glenn Catalano, MD, John N. Greene, MD and Ramon Sandin, MD.

CMS Open Payments shows 31 general payments to Dr. Tsambiras from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Smith & Nephew, Inc. paid the most, $122.

Dmand AI lists 1 award for Dr. Tsambiras, most recently CMS Stage 1 EHR in 2012.

Dr. Tsambiras graduated from USF Health Morsani College of Medicine in 1996.

Dr. Tsambiras is in network with 17 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.